Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia "REVEAL"


Phase N/A Results N/A

Summary of Purpose

The plasma concentration of high-density lipoprotein (HDL) can have anti-inflammatory, anti-oxidative and anti-thrombotic effects in addition to being able to remove cholesterol from peripheral tissues for secretion via the liver. The investigators hypothesise that elevation of plasma HDLs will reduce the inflammatory response following removal of unstable atherosclerotic plaques in the carotid artery. Such ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 June 2015.

1 Feb 2006 13 Jan 2009 1 Dec 2008 1 Feb 2009 1 Jan 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Basic Science
  • Intervention: Parallel Assignment


Not available